Sentinel node biopsy in oral squamous cell carcinoma

Journal of Surgical Oncology

Volumn 96, Issue 4, 2007, Pages 330-336

  Civantos, Francisco ^a   Zitsch, Robert ^b   Bared, Anthony ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

ACOSOG Z0360 validation trial; Lymphatic basin; Mucosal squamous cell carcinoma

Indexed keywords

CANCER RECURRENCE; CANCER SURGERY; EARLY CANCER; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MOUTH CARCINOMA; NECK DISSECTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; TREATMENT INDICATION; CANCER STAGING; CLINICAL TRIAL; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; METHODOLOGY; MOUTH TUMOR; PATHOLOGY; PREDICTION AND FORECASTING; RADIOIMMUNOASSAY; RISK FACTOR; SCINTISCANNING; WOUND DRAINAGE;

CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS; DRAINAGE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MOUTH NEOPLASMS; NECK DISSECTION; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RADIOIMMUNODETECTION; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY;

EID: 34848918222     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20865     Document Type: Review

References (49)

1. Morton DL, Wen D-R, Wong JH, et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
2. Morton DL, Wen D-R, Foshag LJ, et al.: Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 1993;11:1751-1756.
3. Alex JC, Krag DN: The gamma-probe-guided resection of radiolabeled primary lymph nodes. Surg Oncol Clin N Am 1996;5:33.
4. Leong SP: Selective sentinel lymphadenectomy for malignant melanoma. Surg Clin North AM 2003;83:157.
5. Morton DL, Thompson JF, Essner R, et al.: Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999;230:453.
6. Giuliano AE, Kirgan DM, Guenther JM, et al.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391.
7. O'Brien CJ, Uren RF, Thompson JF, et al.: Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995;170:461.
8. Jansen L, Koops HS, Nieweg OE, et al.: Sentinel node biopsy for melanoma in the head and neck region. Head Neck 2000;22:27.
9. de Wilt JH, Thompson JF, Uren RF, et al.: Correlation between preoperative lymphoscintigraphy and metastatic nodal disease sites in 362 patients with cutaneous melanomas of the head and neck. Ann Surg 2004;239:544.
10. Chao C, Wong SL, Edwards MJ, et al.: Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol 2003;10:21.
11. Pillsbury HC, Clark M: A rationale for therapy of the N0 neck. Laryngoscope 1997;107:1294-1315.
12. Clayman GL, Frank DK: Selective neck dissection of anatomically appropriate levels is as efficacious as modified radical neck dissection for elective treatment of the clinically negative neck in patients with squamous cell carcinoma of the upper respiratory and digestive tracts. Arch Otolaryngol Head Neck Surg 1998;124:348-352.
13. Martinez-Gimeno C, Rodriguez EM, Vila CN, et al.: Squamous cell carcinoma of the oral cavity: A clinicopathologic scoring system for evaluating risk of cervical lymph node metastasis. Laryngoscope 1995;105:728-733.
14. Shear M, Hawkins DM, Farr HW: The prediction of lymph node metastases from oral squamous carcinoma. Cancer 1976;37:1901-L 1907.
15. Yuen APW, Wei WI, Wong YM, et al.: Elective neck dissection versus observation in the treatment of early oral tongue carcinoma. Head Neck 1997;19:583-588.
16. Oreste G, Boddi V, Bottai GV, et al.: Treatment of the clinically negative neck in laryngeal cancer patients. Head Neck 1996;18:566-572.
17. Kligerman J, Lima RA, Soares JR, et al.: Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg 1994;168:391-392.
18. Braams JW, Pruim J, Freling NJM, et al.: Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995;36:211-216.
19. Alvi A, Johnson JT: Extracapsular spread in the clinically negative neck (N0): Implications outcome. Otolaryngol Head Neck Surg 1996;114:65-70.
20. Mamelle G, Pampurik J, Luboinski B, et al.: Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg 1994;168:494-498.
21. Rassekh CH, Johnson JT, Myers EN: Accuracy of intraoperative staging of the N0 neck in squamous cell carcinoma. Laryngoscope 1995;105:1334-1336.
22. Pitman KT, Johnson JT, Myers EN, et al.: Effectiveness of the selective neck dissection for the management of the clinically negative neck. Arch Otolaryngol 1997;123:917-922.
23. McGuirt WF, Johnson JT, Myers EN, et al.: The management of the clinically negative neck. Arch Otolaryngol Head Neck Surg 1995;121:278-282.
24. Shingaki S, Kobayashi T, Suzuki I, et al.: Surgical treatment of stage I and II oral squamous cell carcinomas: Analysis of causes of failure. Br J Oral Maxillofac Surg 1995;33:304-308.
25. Shah JP, Andersen PE: Evolving role of modifications in neck dissection for oral squamous cell carcinoma. Br J Oral Maxillofac Surg 1995;33:3-8.
26. Rabuzzi DD, Chung CT, Sagerman RH, et al.: Prophylactic neck irradiation. Arch Otolaryngol 1980;106:454-455.
27. Ross GL, Shoaib T, Soutar DS, et al.: The use of sentinel node biopsy to upstage the clinically N0 neck in head and neck cancer. Arch Otolaryngol Head Neck Surg 2002;128:1287-1290.
28. Shoaib T, Soutar DS, MacDonald DG, et al: The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically N0 neck. Cancer 2001;91:2077-2083.
29. Civantos FJ, Gomez C, Duque C, et al.: Sentinel node biopsy in oral cavity cancer: Correlation with PET scan and immunohistochemistry. Head Neck 2003;25:1.
30. Albertini JJ, Cruse CW, Rapaport D, et al.: Intraoperative radiolymphoscintigraphy improves sentinel node identification in patients with melanoma. Ann Surg 1996;223:214-217.
31. Thompson JF, McCarthy WH, Bosch CMJ, et al.: Sentinel node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995;5:255-260.
32. Messina JL, Reintgen DS, Cruise CW, et al.: Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 1997;4:389.
33. Altinyollar H, Berberoglu U, Celen O: Lymphatic mapping and sentinel lymph node biopsy in squamous cell carcinoma of the lower lip. Eur J Surg Oncol 2002;28:72-74.
34. Weisberg NK, Bertagnolli MM, Becker DS: Combined sentinel lymphadenectomy and Mohs micrographic surgery for high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol 2000;43:483-488.
35. Ross GL, Soutar DS, Gordon MacDonald D, Shoaib T, Camilleri I, Roberton AG, Sorensen JA, Thomsen J, Grupe P, Alvarez J, Barbier L, Santamaria J, Poli T, Massarelli O, Sesenna E, Kovacs AF, Grunwald F, Barzan L, Sulfaro S, Alberti F: Sentinel node biopsy in head and neck cancer: Preliminary results of a multicenter trial. Ann Surg Oncol 11(7):690-696, 2004 Jul.
36. Stoeckli SJ, Pfaltz M, Ross GL, Steinen HC, MacDonald DG, Wittekind C, Soutar DS: The second international conference on sentinel node biopsy in mucosal head and neck cancer. Ann Surg Oncol 2005;12:919-924.
37. Paleri V, Rees G, Arullendran P, Shoaib T, Krishman S: Sentinel node biopsy in squamous cell cancer of the oral cavity and oral pharynx: A diagnostic meta-analysis. Head Neck 2005;27:739-747.
38. Reschly MJ, Messina JL, Zaulyanov LL, et al.: Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma. Dermatol Surg 2003;29:135-140.
39. Stoekli SJ, Steinert H, Pfaltz M, et al.: Sentinel lymph node evaluation in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 2001;125:221-226.
40. Civantos FJ, Moffat FL, Goodwin WJ: Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: contrasts between oral cavity and cutaneous malignancy. The Laryngoscope 2006:116:Part 2.
41. Zitsch RP III, Todd DW, Renner GJ, et al.: Intraoperative radiolymphoscintigraphy for detection of occult nodal metastasis in patients with head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2000;122:662-666.
42. Chepeha DB, Taylor RJ, Chepeha JC, et al.: Functional assessment using Constant's Shoulder Scale after modified radical and selective neck dissection. Head Neck 2002;24:432-436.
43. Kuntz AL, Weymuller EA Jr: Impact of neck dissection on quality of life. Laryngoscope 1999;109:1334-1338.
44. Rogers SN, Ferlito A, Pelliteri PK, Shaha AR, Rinaldo A: Quality of life following neck dissections. (Review) Acta Otolaryngol 2004;124:231-236.
45. Terrell JE, Chepeha DB: Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004;130:401-408.
46. Tannis PJ, Boom RPA, Koops HS, et al.: Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol 2001;8:222-226.
47. Chung CH, Parker JS, Yabrough WG, et al.: Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 2004;5:489-500.
48. Becker MT, Shores CG, Yarbrough WG: Molecular assay to detect metastatic head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:21-27.
49. Raja S, El Hefnay T, Kelly LA, et al.: Temperature-controlled primer limit for multiplexing of rapid, quantitative reverse transcription-PCR assays: Application to intraoperative cancer diagnostics. Clin Chem 2000;48:1329-1337.